Entry |
|
Name |
Molgramostim (USAN/INN) |
Formula |
C639H1007N171O196S8
|
Exact mass |
14468.1853
|
Mol weight |
14477.381
|
Sequence |
APARSPSPST QPWEHVNAIQ EARRLLNLSR DTAAEMNETV EVISEMFDLQ EPTCLQTRLE LYKQGLRGSL TKLKGPLTMM ASHYKQHCPP TPETSCATQI ITFESFKENL KDFLLVIPFD CWEPVQE |
Type |
Peptide |
Class |
Immunological agent
DG01753 Colony stimulating factor
DG01782 Granulocyte macrophage colony-stimulating factors (GM-CSF)
|
Remark |
|
Efficacy |
Antineutropenic, Hematopoietic stimulant, Granulocyte-macrophage colony stimulating factor (GM-CSF) |
Comment |
|
Target |
|
Pathway |
hsa04060 | Cytokine-cytokine receptor interaction |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L03 IMMUNOSTIMULANTS
L03A IMMUNOSTIMULANTS
L03AA Colony stimulating factors
L03AA03 Molgramostim
D05066 Molgramostim (USAN/INN)
Drug groups [BR:br08330]
Immunological agent
DG01753 Colony stimulating factor
DG01782 Granulocyte macrophage colony-stimulating factors (GM-CSF)
D05066 Molgramostim
Target-based classification of drugs [BR:br08310]
Cytokines and receptors
Cytokine receptors
CSF and other factor receptors
CSF2RA (GMCSFR, CD116)
D05066 Molgramostim (USAN/INN)
|
Other DBs |
|
LinkDB |
|